AG Leiter: Assoc. Prof. PD Dr. Martin Bodingbauer
AG Leiter: Medizinische Universität Wien
Universitätsklinik für Chirurgie
Währinger Gürtel 18-20
1090 Wien
Tel: +43-1-40400-56210
Fax: +43-1-40400-56410
Email: martin.bodingbauer@meduniwien.ac.at
Stellvertreter:
OA Dr. Helwig Wundsam
helwig.wundsam@Âordensklinikum.at
Aktuelles aus der Arbeitsgruppe
Literaturhinweise
19. 03.2019- Age independent survival benefit for patients with hepatocellular carcinoma (HCC) without metastases at diagnosis: a population-based study.
- Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.
- Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.
- Systematic review and meta-analysis of laparoscopic versus open repeat hepatectomy for recurrent liver cancer.
- Impact of Anatomical Versus Non-anatomical Liver Resection on Short- and Long-Term Outcomes for Patients with Intrahepatic Cholangiocarcinoma.
- Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery.
- Nonresectional regional therapies for metastatic colorectal cancer to the liver.
- Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
- Robotic hepatectomy for benign and malignant liver tumors.
- Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma.
- Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.
Literaturhinweise
25. 02.2019- Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
- Malnutrition associated with an increased risk of postoperative complications following hepatectomy in patients with hepatocellular carcinoma.
- Influence of tumor-free resection margins on overall and disease-free survival after resection of colorectal liver metastases.
- Partial liver resection vs. transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria and portal hypertension.
Chirurg 2019
- Liver resection for hepatocellular carcinoma with portal vein infiltration.
- Importance of the lymph node status in patients with hilar cholangiocarcinoma.
- Perihilar cholangiocarcinoma Bismuth type IV: Resection frequently possible.
- Importance of repeated liver resection in recurrent intrahepatic cholangiocarcinoma.
- Treatment effect of liver resection vs. RFA or TACE in hepatocellular carcinoma.
- Importance of portal vein embolization depending on the underlying hepatic malignancy.
- Unresectable intrahepatic cholangiocarcinoma: 50 % resectability after neoadjuvant therapy.
- Surgical therapy of primary hepatic angiosarcoma.
- Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.
Literaturhinweise
18. 02.2019- Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma.
- Initial experience with irreversible electroporation of liver tumours.
- The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- Epidemiology and Management of Hepatocellular Carcinoma.
- Primary Tumor Versus Liver-First Approach for Synchronous Colorectal Liver Metastases: An Association Française de Chirurgie (AFC) Multicenter-Based Study with Propensity Score Analysis.
- Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
- Short- and Long-term Outcomes after Robotic and Laparoscopic Liver Resection for Malignancies: A Propensity Score-Matched Study.
- Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.
- Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis.
- Multidisciplinary approach of liver metastases from colorectal cancer.
- Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.
- Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.
- Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?
- Minimal-invasive versus open hepatectomy for hepatocellular carcinoma: Comparison of postoperative outcomes and long-term survivals using propensity score matching analysis.
- Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.
- The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
- Development of novel biological resection criteria for safe and oncologically satisfying resection of hepatocellular carcinoma.
- Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.
- Surgical resection of neuroendocrine tumor liver metastases as part of multimodal treatment strategies: A propensity score matching analysis.
- Laparoscopic resection of caudate lobe. Technical strategies for a difficult liver segment – Video article.
- Surgery for perihilar cholangiocarcinoma.
- Biomarkers in colorectal liver metastases.
- Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?
- Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
- Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
- Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.
- Surgical resection for Bismuth type IV perihilar cholangiocarcinoma.